Abstract
A substrain of the senescence-accelerated mouse (SAM), the SAMP1 mouse, is an animal model for accelerated senescence including the age-related acceleration of both immunological dysfunction and hearing loss caused by the impairment of spiral ganglion cells. In the present study, we examine whether the accelerated presbycusis can be prevented by allogeneic BMT. Young SAMP1 (H-2k) mice were irradiated with 9 Gy and then reconstituted with bone marrow cells from normal BALB/c (H-2d) mice. Allogeneic BMT was found to prevent the development of immunological dysfunction, hearing loss, and apoptosis of spinal ganglion cells in SAMP1 mice. These findings indicate that some types of accelerated presbycusis do not result from defects in the cochlea, but do from defects in the hematopoietic stem cells (HSC) and immunocompetent cells derived from the HSC. If this is the case, either allogeneic BMT, which replaces abnormal HSC with normal HSC and reconstructs a normal immune system in the recipients, or autologous BMT using genetically modified bone marrow cells, could become a new strategy for the treatment of presbycusis. Bone Marrow Transplantation (2001) 28, 323–328.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gates GA, Myers RH . Genetic associations in age-related hearing thresholds Arch Otolaryngol Head Neck Surg 1999 125: 654–659
Paparella MM, Hansson DG, Rao KN, Ulvestad R . Genetic sensorineural deafness in adults Ann Otol Rhinol Laryngol 1975 84: 459–472
Chen AH, Muller RF, Pradad SD et al. Presymptomatic diagnosis of nonsyndromic hearing loss by genotyping Arch Otolaryngol Head Neck Surg 1998 124: 20–24
Hosono M, Hanada K, Toichi E et al. Immune abnormality in relation to nonimmune diseases in SAM mice Exp Gerontol 1997 32: 181–195
Saitoh Y, Hosokawa M, Shimada A et al. Age-related hearing impairment in senescence-accelerated mouse (SAM) Hear Res 1994 75: 27–37
Kitado H, Higuchi K, Takeda TJ . Molecular genetic characterization of the senescence-accelerated mouse (SAM) strains Gerontol 1994 49: B247–B254
Odagiri Y, Uchida H, Hosokawa M et al. Accelerated accumulation of somatic mutations in the senescence-accelerated mouse Nature Genet 1998 19: 116–117
Hosokawa T, Hosono M, Higuchi K et al. Immune responses in newly developed short-lived SAM mice. I. Age-associated early decline immune activities of cultured spleen cells Immunology 1987 62: 419–423
Takeda T, Hosokawa M, Takeshita S et al. A new murine model of accelerated senescence Mech Aging Dev 1981 17: 183–194
Hosokawa M, Kasai R, Higuchi K et al. Grading score system: a method for evaluation of the degree of senescence in senescence accelerated mouse (SAM) Mech Aging Dev 1984 26: 91–102
Yoshioka H, Yoshida H, Doi T et al. Autoimmune abnormalities in a murine model of accelerated senescence Clin Exp Immunol 1989 75: 129–135
Iwai H, Tomoda K, Hosaka N et al. Induction of immune-mediated hearing loss in SCID mice by injection of MRL/lpr mouse spleen cells Hear Res 1998 117: 173–177
Lee S, Iwai H, Sugiura K et al. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation Bone Marrow Transplant 2000 26: 887–892
Iwai H, Yasumizu R, Sugiura K et al. Successful pancreatic allografts in combination with bone marrow transplantation in mice Immunology 1987 62: 457–462
Backoff PM, Caspary DM . Age-related changes in auditory brainstem responses in Fischer 344 rats: effects of rate and intensity Hear Res 1994 73: 163–172
Costa P, Benna P, Bianco C et al. Aging effects on brainstem auditory evoked potentials Electromyogr Clin Neurophysiol 1990 30: 495–500
Gavrieli Y, Sherman Y, Ben-Sasson SA . Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J Cell Biol 1992 119: 493–501
Usami S, Takumi Y, Fujita S et al. Cell death in the inner ear associated with aging is apoptosis? Brain Res 1997 747: 147–150
Bunting KD, Flynn KJ, Riberdy JM et al. Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency Proc Natl Acad Sci USA 1999 96: 232–237
Iwai H, Tomoda K, Sugiura K et al. T cells infiltrating from the systemic circulation proliferate in the endolymphatic sac Ann Otol Rhinol Laryngol 1999 108: 1146–1150
Lazarov-Spiegler O, Solomon AS, Zeev-Brann AB et al. Transplantation of activated macrophages overcomes central nervous system regrowth failure FASEB J 1996 10: 1296–1302
David S, Bouchard C, Tsatas O et al. Macrophages can modify the nonpermissive nature of the adult mammalian central nervous system Neuron 1990 5: 463–469
Dinarello CA . Interleukin-1 Rev Infect Dis 1984 6: 51–95
Hahn M, Lorez H, Fischer G . Effect of calcitriol in combination with corticosterone, interleukin-1β, and transforming growth factor-β1 on nerve growth factor secretion in an astroglial cell line J Neurochem 1997 69: 102–109
Saporito MS, Wilcox HM, Hartpence KC et al. Pharmacological induction of nerve growth factor mRNA in adult rat brain Exp Neurol 1993 123: 295–302
Fagan AM, Gage FH . Cholinergic sprouting in the hippocampus: a proposed role for IL-1 Exp Neurol 1990 110: 105–120
Capsoni S, Ugolini G, Comparini A et al. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice Proc Natl Acad Sci USA 2000 97: 6826–6831
Thoenen H, Bandtlow C, Heumann R . The physiological function of nerve growth factor in the central nervous system Rev Physiol Biochem Pharmacol 1987 109: 145–178
Connor B, Dragunow M . The role of neuronal growth factors in neurodegenerative disorders of the human brain Brain Res Rev 1998 27: 1–39
Komeda M, Roessler BJ, Raphael Y . The influence of interleukin-1 receptor antagonist transgene on spiral ganglion neurons Hear Res 1999 131: 1–10
Subramanian S, Bourdette DN, Corless C et al. T lymphocytes promote the development of bone marrow-derived APC in the central nervous system J Immunol 2001 166: 370–376
Acknowledgements
We thank Ms K Ando for her help in the preparation of the manuscript. This study was supported by grants-in-aid for scientific research (11671712) from the Ministry of Education, Science, Sports and Culture, by a special research grant (C1) from the Japan Private School Promotion Foundation, and by a research grant for Intractable Diseases (Vestibular Disorders) from the Ministry of Health and Welfare.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iwai, H., Lee, S., Inaba, M. et al. Prevention of accelerated presbycusis by bone marrow transplantation in senescence-accelerated mice. Bone Marrow Transplant 28, 323–328 (2001). https://doi.org/10.1038/sj.bmt.1703152
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703152
Keywords
This article is cited by
-
Role of antioxidants in prevention of age-related hearing loss: a review of literature
European Archives of Oto-Rhino-Laryngology (2017)
-
Overexpression of X-Linked Inhibitor of Apoptotic Protein (XIAP) reduces age-related neuronal degeneration in the mouse cochlea
Gene Therapy (2014)
-
Environmental and genetic factors in age-related hearing impairment
Aging Clinical and Experimental Research (2011)
-
Advances in Molecular and Cellular Therapies for Hearing Loss
Molecular Therapy (2008)